These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 4957)

  • 21. Effects of long use of a beta-blocker, carteolol, on exercise hemodynamics in hypertensives.
    Katori R; Tashi M; Ohno M; Oogai T; Morishita M; Morii S
    Jpn Circ J; 1985 Jan; 49(1):52-60. PubMed ID: 3968862
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative hemodynamic studies in man of adrenergic bepta-1-receptors agents without (h 93/26 equal to metoprolol) or with (h 87/07) intrinsic sympathicomimetic activity.
    Stenberg J; Wasir H; Amery A; Sannerstedt R; Werkö L
    Acta Pharmacol Toxicol (Copenh); 1975; 36(Suppl 5):76-84. PubMed ID: 237401
    [No Abstract]   [Full Text] [Related]  

  • 23. Clinical, electrocardiographic, and hemodynamic effects of ICI 89,406, a new cardioselective beta-adrenoceptor antagonist with intrinsic sympathomimetic activity, in patients with angina pectoris.
    Majid PA; Schreuder JE; de Feyter PJ; Roos JP
    J Cardiovasc Pharmacol; 1980; 2(4):435-44. PubMed ID: 6156341
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hemodynamic changes at rest and during exercise in long-term clonidine therapy of essential hypertension.
    Lund-Johansen P
    Acta Med Scand; 1974; 195(1-2):111-5. PubMed ID: 4817078
    [No Abstract]   [Full Text] [Related]  

  • 25. Role of cardiac factors in the initial hypotensive action by beta-adrenoreceptor blocking agents.
    Colfer HT; Cottier C; Sanchez R; Julius S
    Hypertension; 1984; 6(2 Pt 1):145-51. PubMed ID: 6144632
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute and chronic haemodynamic effects of doxazosin in hypertension at rest and during exercise.
    Lund-Johansen P; Omvik P; Haugland H
    Br J Clin Pharmacol; 1986; 21 Suppl 1(Suppl 1):45S-54S. PubMed ID: 2939867
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Haemodynamic long-term effects of prazosin plus tolamolol in essential hypertension.
    Lund-Johansen P
    Br J Clin Pharmacol; 1977 Apr; 4(2):141-5. PubMed ID: 577181
    [No Abstract]   [Full Text] [Related]  

  • 28. Chronic hemodynamic effects of tiapamil and felodipine in essential hypertension at rest and during exercise.
    Lund-Johansen P; Omvik P
    J Cardiovasc Pharmacol; 1990; 15 Suppl 4():S42-7. PubMed ID: 1693726
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Timolol maleate (Blocadren) in the treatment of essential hypertension.
    O'Brien KP
    N Z Med J; 1975 Nov; 82(551):293-6. PubMed ID: 1695
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hemodynamic adjustments in hypertensive patients developing circulatory congestion during beta-adrenergic blockade.
    Reybrouck T; Amery A; Billiet L; Fagard R
    Cardiology; 1979; 64(2):97-109. PubMed ID: 436128
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Haemodynamic effects of combined alpha- and beta-adrenoreceptor blockade after intravenous labetalol in hypertensive patients at rest and during exercise.
    Koch G
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):725-8. PubMed ID: 10950
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chronic beta adrenergic blockade in arterial hypertension. Hemodynamic influences of dihydralazine and dynamic exercise and clinical effects of combined treatment.
    Sannerstedt R; Stenberg J; Vedin A; Wilhelmsson C; Werkö L
    Am J Cardiol; 1972 May; 29(5):718-23. PubMed ID: 4401785
    [No Abstract]   [Full Text] [Related]  

  • 33. Comparison of the hemodynamic effects of five calcium channel blockers at rest and during exercise in essential hypertension.
    Omvik P; Lund-Johansen P
    Ann Clin Res; 1988; 20 Suppl 48():23-30. PubMed ID: 3250315
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term haemodynamic effects of enalapril (alone and in combination with hydrochlorothiazide) at rest and during exercise in essential hypertension.
    Lund-Johansen P; Omvik P
    J Hypertens Suppl; 1984 Dec; 2(2):S49-56. PubMed ID: 6100877
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Some cardiovascular effects of timolol a new beta-adrenergic blocking agent.
    Scriabine A; Torchiana ML; Stavorski JM; Ludden CT; Minsker DH; Stone CA
    Arch Int Pharmacodyn Ther; 1973 Sep; 205(1):76-93. PubMed ID: 4148410
    [No Abstract]   [Full Text] [Related]  

  • 36. Hemodynamic effects during rest and exercise of bucindolol in hypertensive men.
    Conner DP; Vlasses PH; Clementi RA; Oren A; Deitchman D; Ferguson RK
    J Clin Pharmacol; 1987 Apr; 27(4):300-3. PubMed ID: 2890669
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rest and exercise hemodynamic effects of sequential alpha-1-adrenoceptor (trimazosin) and beta-adrenoceptor (propranolol) antagonism in essential hypertension.
    Nelson GI; Silke B; Hussain M; Verma SP; Taylor SH
    Am Heart J; 1984 Jul; 108(1):124-31. PubMed ID: 6731261
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hemodynamic effects of practolol at rest and during exercise.
    Leon DF; Thompson ME; Shaver JA; McDonald RH
    Circulation; 1972 Jan; 45(1):46-54. PubMed ID: 4399771
    [No Abstract]   [Full Text] [Related]  

  • 39. A comparison of timolol and propranolol in essential hypertension.
    Lohmöller G; Frohlich ED
    Am Heart J; 1975 Apr; 89(4):437-42. PubMed ID: 234668
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Haemodynamic effects of four months' mefruside therapy in hypertensive patients.
    Bevegård S; Castenfors J; Danielson M
    Acta Med Scand; 1977 Jan; 201(1-2):93-7. PubMed ID: 835379
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.